Chapter 48 The dean came to the door in person (please seek monthly votes for reading!)
Zhang Yang did not continue the simulation. The long simulation consumed a lot of energy on him.
However.
Before exiting the simulator, he still extracted the patent for the crystal form of "Icofenprofovir" that can cure hepatitis B as usual.
After finishing all this, he lay on the sofa and began to think about how to put this drug on the market.
Compared to "Aoyama Ava" or "ITG Human Myelopoietin", he knew that this drug that could cure hepatitis B could never be compared to the first two drugs in terms of social influence and audience size.
Especially social influence is not a level at all!
Just kidding, there are only about 1.5 million patients suffering from "aplastic anemia" in Potian country, and there are only about 1.5 million patients suffering from hepatitis B!
120 million!
It is equivalent to one in ten Chinese people being infected!
Therefore, once this drug is actually launched, it will inevitably cause shock across the country. At that time, you and Qingshan Pharmaceutical will definitely be at the forefront.
How will you justify yourself and explain the source of drug research and development?
Zhang Yang thought for a long time but couldn't think of a good way.
“No matter what… let’s take it easy for now!”
“The most important issue now is to complete the third clinical phase of ‘ITG human myelopoietin’ as soon as possible…”
"Besides this, I don't know how the progress of 'Avatrombopag' entering the hospital is going. Next, whether it is 'ITG Generator' or hepatitis B drug clinical trials, a lot of money will be needed, and it all depends on 'Qingshan' Ava's sales profit support, don't let any surprises happen..."
"By the way, the laboratory R&D team also needs to expand its recruitment, which is also an expense..."
Thinking about it, Zhang Yang fell into a drowsy sleep.
……
The next morning, at 7:30, Zhang Yang woke up.
After a simple wash and breakfast, he came to the company and began to recall step by step his thoughts before going to bed last night.
That’s right.
The first thing is to expand the laboratory R&D team.
At present, there are only 4 professional drug developers in Qingshan Pharmaceutical, including himself.
The previous "Qingshan Ava" and "ITG human genitin" can still be used "Zhang Yang is extremely talented in the research and development of blood disease drugs" to explain. If a drug that can cure hepatitis B is developed next, how to explain it?
My boss Zhang Yang also has a little talent for liver disease?
“Okay, don’t ask for the quality of personnel first, let’s get the quantity up first!”
“Real pharmaceutical masters are hard to find, but are there still few pharmaceutical college students with three legs?”< br>
“It’s just that the salary payment is The output suddenly increased several times..."
Zhang Yang did not expect the recruited drug research and development personnel to make any breakthroughs. The recruitment information was quickly sent out, and at the same time, a "Hepatitis B Drug Research and Development Team" was established. He himself serves as the group leader.
After finishing the recruitment matter, Zhang Yang shifted his attention to the clinical phase III of "ITG human myelopoietin".
The clinical phase III of "ITG human genin" requires a total of 550 trial subjects. Although there are some hiccups, more than 120 people have been successfully recruited so far.
The remaining places are expected to be filled within a month.
Zhang Yang is not worried about "ITG human myelopoietin" passing the third phase. A drug like this that can achieve complete cure will generally pass quickly as long as there are no major side effects!
Thinking of this, he set his sights on Tsingshan Pharmaceutical's only single product and the only source of profit - "Tsingshan Avatrombopag".
Now that "Qingshan Afa" has entered the sales cycle, I don't know how Ren Xiaomin's progress in promoting "Qingshan Afa" has been admitted this week?
“It should be pretty good, right?”
“After all, ‘Qingshan Ava’ not only has excellent medicinal effects, but has also been included in the medical insurance catalog. It should be easy to get into a tertiary hospital.”
But at three o'clock in the afternoon, when Ren Xiaomin came to the office a little depressed, Zhang Yang's heart tightened, and he realized that this matter might not go as smoothly as he imagined.
“Brother Ren, what’s wrong? The admission sales are not going well?”
"Zhang Yang, I think we underestimated the AkaRx company. To be precise, we underestimated the influence of their partner, Fuxing Pharmaceutical, in the hospital." "This week, we have made almost no progress in entering the hospital."
Zhang Yang was not in a hurry, but poured a glass of water for Ren Xiaomin.
"Brother Ren, speak slowly, don't be anxious, what's going on."
"Yeah."
Ren Xiaomin picked up the cup and took a sip:
"Our 'Qingshan Pharmaceutical Sales Company' is a new company after all, and we don't have any hospital connections, so my idea is to start with our local top-level hospitals in Chengdu and talk about them one by one. "
"We have negotiated with two or three tertiary hospitals in surrounding counties and districts, and all the drugs have been admitted to the hospital, but you also You know, there are differences between tertiary tertiary hospitals and tertiary tertiary hospitals. There are not many patients in the hematology departments of tertiary hospitals in these counties, so the purchasing volume is very limited. A purchase of two to three hundred thousand is quite a lot."
"So, my focus is still on the really large tertiary hospitals, such as Xihua Hospital."
"Xihua Hospital?"
Zhang Yang nodded slightly, agreeing with Ren Xiaomin's thinking.
Xihua Hospital has a strong influence across the country. In the latest comprehensive ranking of Huaxia Hospitals, Xihua Hospital has ranked second for 15 consecutive years.
Although the Department of Hematology is not one of the top departments in Xihua, this is Xihua!
So!
If you can enter the pharmacy of Xihua Hospital to sell, the monthly sales amount will not be hundreds of thousands...
"What happened? Talk broke down?" Zhang Yang asked.
"It's okay if the talks fall apart. This week, both the department director and the person in charge of the pharmacy department have avoided seeing each other. It's been a week and I haven't even seen anyone!"
"Careful Thinking about it, I guess Fuxing Pharmaceutical is behind it. After all, now What Xihua Hospital purchases is their 'Avatrombopag'."
As he spoke, Ren Xiaomin sighed:
"I really realized that sentence, medicine. Sales is definitely not about fighting, it’s about worldly relationships..."
Zhang Yang didn't find it strange at all. After all, in a channel that requires human resources, there's really nothing you can do if you don't have some connections.
But after a moment, he suddenly asked:
"Can the current profits of 'Qingshan Ava' support the clinical phase III of 'ITG human genitin'?"
"That's enough! It's no problem to support the completion of the third clinical phase!"
Zhang Yang felt relieved and his thoughts gradually became clearer. He patted Ren Xiaomin's shoulder and comforted:
"In this case, Brother Ren, don't be too stressed, just take your time."
"They have reason to reject 'Avatrombopag' now. I want to take a look and wait until 'ITG human bone marrow is produced. After Su' goes on the market, how many hospitals will refuse..."
Ren Xiaomin was stunned for a moment, and then understood what Zhang Yang meant.
With the failure of "Qingshan Afa" to be admitted, Zhang Yang did not want to continue to force "Qingshan Afa" to be admitted.
After comforting Ren Xiaomin for a few words, he then focused all his energy on the clinical phase III of "ITG human myelopoietin" and subsequent production processes and production approval documents!
This is the medicine that can cure "aplastic anemia"!
Which hospital with a hematology department will not purchase it by then? !
Soon, one month later.
The clinical data of the first month of the third clinical phase of "ITG human myelopoietin" was released on the official website of the Food and Drug Administration!
In just one month of treatment, some subjects’ bone marrow hematopoietic stem cells actually showed functional improvement!
As soon as the news came out, domestic pharmaceutical companies were shocked, and it instantly caused a sensation within the industry!
When the clinical data came out in the second month, major pharmaceutical companies were even more shocked.
After two months of medication, the effective response of participating clinical subjects increased significantly, and the bone marrow cell proliferation of some patients began to return to normal!
In other words, it is almost certain that "ITG human myelopoietin" is really effective in treating aplastic anemia!
The news quickly spread throughout the industry, but what Zhang Yang didn’t expect was that
Domestic pharmaceutical companies were not in a hurry. Instead, President Zhou from the Third People's Hospital of Chengdu came to the door first!
"Hello, Mr. Zhang. I have wanted to talk to you before, but I have never seen you."
"This time, I am going to discuss a cooperation with you. "
Looking at Director Zhou of the Third People's Hospital of Chengdu, Zhang Yang was a little confused.
Hospital?
cooperate? !
(End of this chapter)